Skip to main content

uniQure to Participate in Multiple Upcoming Industry Conferences in September

Written by Customer Service on . Posted in Public Companies.

LEXINGTON, Mass. and AMSTERDAM, Sept. 03, 2020 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that Matt Kapusta, chief executive officer at uniQure, Maria Cantor, senior vice president of investor relations and communications, and Chiara Russo, associate director of investor relations and communications, will participate in the following upcoming conferences in September:
Citi’s 15th Annual BioPharma Virtual Conference, September 9 – 10, 2020
 A fireside chat with research analyst Shawn Egan will take place on Wednesday, September 9, 2020 from 9:50 – 10:35 a.m. ET. The live webcast of the chat can be accessed through the link displayed in the Investor section of the uniQure website. The webcast replay will be available for at least 72 hours following the live event.
 Members of uniQure’s management team will participate in virtual one-on-one investor meetings throughout the day on Wednesday, September 9th.
 Baird’s Virtual Global Healthcare Conference, September 9 – 10, 2020
 Members of uniQure’s management team will participate in virtual one-on-one investor meetings in the afternoon on Wednesday, September 9, 2020.
 Wells Fargo Global Healthcare Conference, September 9 – 10, 2020 (Virtual)
 A fireside chat with research analyst Jim Birchenough will take place on Thursday, September 10, 2020 from 10:00 – 10:30 a.m. ET. The live webcast of the chat can be accessed through the link displayed in the Investor section of the uniQure website. The webcast replay will be available for at least 72 hours following the live event.
 Members of uniQure’s management team will participate in virtual one-on-one investor meetings throughout the day on Thursday, September 10th.
 H.C. Wainwright 22nd Annual Global Investment Conference, September 14 – 15, 2020 (Virtual)
 A fireside chat with research analyst Debjit Chattopadhyay will take place on Monday, September 14, 2020 from 9:30 – 9:50 a.m. ET. The live webcast of the corporate update can be accessed through the link displayed in the Investor section of the uniQure website. The webcast replay will be available for at least 72 hours following the live event.
 Members of uniQure’s management team will participate in virtual one-on-one investor meetings during the morning of Monday, September 14, 2020.
 Cantor Fitzgerald Virtual Global Healthcare Conference, September 15 – 17, 2020
 A fireside chat with analyst Eliana Merle will take place on Wednesday, September 16, 2020 from 9:30 – 9:50 a.m. ET.  The live webcast of the corporate update can be accessed through the link displayed in the Investor section of the uniQure website. The webcast replay will be available for at least 72 hours following the live event.
 Members of uniQure’s management team will participate in virtual one-on-one investor meetings throughout the day on Wednesday, September 16, 2020.
 Barclays Boston Biotech Bus Trip, September 23 – 25, 2020 (Virtual)
 An interactive group meeting with investors, moderated by research analyst Gena Wang will take place on Friday, September 25, 2020 from 2:15 – 3:15 p.m. ET.About uniQure
uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary gene therapies to treat patients with hemophilia B, Huntington’s disease, Fabry disease, spinocerebellar ataxia Type 3 and other diseases. www.uniQure.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.